Acquisition | Healthcare
Macquarie acquired 40% of Luz Saúde from Fidelidade. The agreement was announced in September 2025 and the target confirms completion on 29 January 2026.
The transaction
Macquarie announced an approximately €310m price and intended support for healthcare expansion, technology and digitalisation.
The annual report records post-transaction holdings of 40% for MEIF 7 Med Bidco, 59.86% for Fidelidade and 0.14% for other shareholders.
Evidence behind the record
5 Sept 2025
Facts are attributed to the public sources above. The Portus view is our interpretation.
Return to your resultsExplore funds and managers
Portuguese Fund DirectoryBrowse fund records, manager profiles and publicly disclosed investment information.
From the market to your business
Portus provides corporate advisory and introduces companies to independent funds and managers. Share your company's plans so we can assess the fit and discuss the next step.